通腑解郁方治疗痰热扰神型卒中后抑郁临床研究OA
Clinical Study on Tongfu Jieyu Prescription for Post-Stroke Depression with Phlegm-Heat Disturbing the Spirit Type
目的:观察通腑解郁方辅助治疗痰热扰神型卒中后抑郁(PSD)的临床疗效.方法:选择2024年1-9月浙江中医药大学附属温州市中医院收治的106例痰热扰神型PSD患者,按随机数字表法分为中医组和西医组各53例.西医组给予盐酸氟西汀胶囊口服,中医组给予通腑解郁方治疗.治疗8周后,比较2组临床疗效和不良反应发生率,以及治疗前后抑郁评分[汉密尔顿抑郁量表(HAMD)和抑郁自评量表(SDS)]、中医证候评分、匹兹堡睡眠质量指数(PSQI)评分、神经递质[5羟色胺(5-HT)、去甲肾上腺素(NE)、多巴胺(DA)]水平.结果:治疗后,中医组总有效率为84.91%(45/53),对照组为79.25%(42/53),2组比较,差异无统计学意义(P>0.05).治疗后,2组HAMD评分、SDS评分均较治疗前降低(P<0.05),2组HAMD评分、SDS评分比较,差异无统计学意义(P>0.05).治疗后,2组中医证候主、次症评分及总分均较治疗前降低(P<0.05),且中医组2项评分及总分均低于西医组(P<0.05).治疗后,2组PSQI评分均较治疗前降低(P<0.05),且中医组评分低于西医组(P<0.05).治疗后,2组 5-HT、NE、DA 水平均较治疗前升高(P<0.05),且中医组NE、DA水平均高于西医组(P<0.05);2组5-HT水平比较,差异无统计学意义(P>0.05).治疗期间,中医组不良反应发生率为3.77%(2/53),西医组为20.75%(11/53),组间比较,差异有统计学意义(P<0.05).结论:通腑解郁方治疗痰热扰神型PSD可调节血清神经递质水平,减轻患者抑郁症状,进一步改善中医证候和睡眠质量,提高临床疗效,且不良反应相对较少.
Objective:To observe the clinical efficacy of Tongfu Jieyu Prescription as adjuvant therapy for post-stroke depression(PSD)of phlegm-heat disturbing the spirit type.Methods:A total of 106 PSD patients of phlegm-heat disturbing the spirit type treated at Wenzhou Traditional Chinese Medicine Hospital of Zhejiang Chinese Medical University from January to September 2024 were randomly divided into a traditional Chinese medicine group(n=53,treated with Tongfu Jieyu Prescription)and a western medicine group(n=53,treated with Fluoxetine Hydrochloride Tablets).After eight weeks of treatment,clinical efficacy,incidence of adverse reactions,as well as depression scores[Hamilton Depression Scale(HAMD)and Self-Rating Depression Scale(SDS)],traditional Chinese medicine syndrome scores,Pittsburgh Sleep Quality Index(PSQI)scores,and neurotransmitter levels[5-hydroxytryptamine(5-HT),norepinephrine(NE),dopamine(DA)]before and after treatment were compared between the two groups.Results:After treatment,the total effective rate was 84.91%(45/53)in the traditional Chinese medicine group and 79.25%(42/53)in the western medicine group,with no significant difference(P>0.05).HAMD and SDS scores decreased in both groups(P<0.05),with no significant difference between the two groups(P>0.05).The traditional Chinese medicine syndrome scores(primary symptoms,secondary symptoms,and total scores)decreased in both groups(P<0.05),with lower scores in the traditional Chinese medicine group(P<0.05).PSQI scores decreased in both groups(P<0.05),with lower scores in the traditional Chinese medicine group(P<0.05).Levels of 5-HT,NE,and DA increased in both groups(P<0.05),with higher NE and DA levels in the traditional Chinese medicine group(P<0.05);no significant difference was found in 5-HT levels between groups(P>0.05).During treatment,the incidence of adverse reactions was 3.77%(2/53)in the traditional Chinese medicine group and 20.75%(11/53)in the western medicine group,showing a significant difference(P<0.05).Conclusion:Tongfu Jieyu Prescription can regulate serum neurotransmitter levels,alleviate depressive symptoms,improve traditional Chinese medicine syndrome manifestations and sleep quality,and enhance clinical efficacy in PSD patients of phlegm-heat disturbing the spirit type,and has relatively fewer adverse reactions.
林秀慧;张露咪;张慧和;吴志敏;赵娜
浙江中医药大学附属温州市中医院,浙江 温州 325000浙江中医药大学附属温州市中医院,浙江 温州 325000浙江中医药大学附属温州市中医院,浙江 温州 325000浙江中医药大学附属温州市中医院,浙江 温州 325000浙江中医药大学附属温州市中医院,浙江 温州 325000
医药卫生
卒中后抑郁痰热扰神通腑解郁方睡眠质量神经递质
Post-stroke depressionPhlegm-heat disturbing the spiritTongfu Jieyu PrescriptionSleep qualityNeurotransmitter
《新中医》 2026 (16)
40-45,6
2022年温州市基础性科研项目(Y20220004)
评论